0
likes
0
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
The evolving landscape of migraine treatment and prevention Analytics Table
Income Estimates for The evolving landscape of migraine treatment and prevention
Based on this YouTube video's total view count of 66 views and industry-standard rates, the estimated total earning is $0 - $0 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About The evolving landscape of migraine treatment and prevention
Explore The evolving landscape of migraine treatment and prevention with 66 views, 0 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.
Uwe Reuter, MD, PhD, MBA, Charité - University Medicine Berlin, Berlin, Germany, outlines the evolving landscape of migraine treatment, including lasmiditan, a serotonin (5-HT)1F receptor agonist and small molecule CGRP receptor antagonists such as ubrogepant and rimegepant. For migraine prevention, Prof. Reuter highlights eptinezumab, an anti-CGRP monoclonal antibody. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard